Precedent Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Precedent Wealth Partners's AMGN Position: Q3 2026 in Review
Precedent Wealth Partners reduced its Amgen (AMGN) stake by 2.3% in Q3 2026, selling an estimated $16.3K and leaving 1,747 shares worth $736K. The position accounts for 0.11% of the portfolio, ranked #126.
Precedent Wealth Partners first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.87M in Q1 2026. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Precedent Wealth Partners held 1,747 shares of Amgen worth $736K as of Q3 2026.
- Precedent Wealth Partners sold 41 Amgen shares in Q3 2026, an estimated $16.3K.
- Amgen made up 0.11% of Precedent Wealth Partners's portfolio in Q3 2026, its #126 holding.
- Precedent Wealth Partners first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
- Precedent Wealth Partners's Amgen position peaked at $2.87M in Q1 2026.
- 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Precedent Wealth Partners's 13F filing for Q3 2026, filed 21 Oct 2026.